University of Southern California
USC Norris Comprehensive Cancer Center

Translational Research

The goal of translational research is to shorten the time it takes for a lab discovery to reach a patient's bedside as a new therapy or tool. Examples of promising treatments still under investigation by basic and clinical scientists at the USC Norris Comprehensive Cancer Center include immunotherapy, gene therapy and anti-angiogenesis drugs.

In addition, USC Norris scientists blending basic and clinical approaches have made huge progress in immunotherapeutic research in cancer, with the development of tumor antibodies as therapeutic tools, and the use of novel cytokines administered via inhalation. Of particular importance has been the study of vaccines for patients with malignant melanoma or cervical cancer, as well as the utility of bio-specific antibodies to target prostate cancer cells.

Developmental Therapeutics Program